AstraZeneca Imfinzi combination fails advanced lung cancer study - Reuters

AstraZeneca Imfinzi combination fails advanced lung cancer study  Reuters

(Reuters) - A combination of AstraZeneca's lung cancer drug Imfinzi and an experimental treatment failed to extend the lives of patients with advanced non-small ...



Comments

Popular posts from this blog

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Oncology: The disease, dynamics & challenges of market research

Division of Continuing Professional Development